» Articles » PMID: 37968615

PathExpSurv: Pathway Expansion for Explainable Survival Analysis and Disease Gene Discovery

Overview
Publisher Biomed Central
Specialty Biology
Date 2023 Nov 16
PMID 37968615
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the field of biology and medicine, the interpretability and accuracy are both important when designing predictive models. The interpretability of many machine learning models such as neural networks is still a challenge. Recently, many researchers utilized prior information such as biological pathways to develop neural networks-based methods, so as to provide some insights and interpretability for the models. However, the prior biological knowledge may be incomplete and there still exists some unknown information to be explored.

Results: We proposed a novel method, named PathExpSurv, to gain an insight into the black-box model of neural network for cancer survival analysis. We demonstrated that PathExpSurv could not only incorporate the known prior information into the model, but also explore the unknown possible expansion to the existing pathways. We performed downstream analyses based on the expanded pathways and successfully identified some key genes associated with the diseases and original pathways.

Conclusions: Our proposed PathExpSurv is a novel, effective and interpretable method for survival analysis. It has great utility and value in medical diagnosis and offers a promising framework for biological research.

Citing Articles

Beyond the black box with biologically informed neural networks.

Selby D, Sprang M, Ewald J, Vollmer S Nat Rev Genet. 2025; .

PMID: 40038452 DOI: 10.1038/s41576-025-00826-1.

References
1.
Worst T, Waldbillig F, Abdelhadi A, Weis C, Gottschalt M, Steidler A . The EEF1A2 gene expression as risk predictor in localized prostate cancer. BMC Urol. 2017; 17(1):86. PMC: 5604352. DOI: 10.1186/s12894-017-0278-3. View

2.
Zhou J, Zhu X, Wu S, Chen H, Chen Y . Glycoprotein hormone α-subunit promotes cell proliferation and tumorigenesis in breast cancer. Oncol Lett. 2022; 23(5):142. PMC: 8931806. DOI: 10.3892/ol.2022.13263. View

3.
Li H, Yang P, Wang J, Zhang J, Ma Q, Jiang Y . HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk. J Hematol Oncol. 2022; 15(1):2. PMC: 8740349. DOI: 10.1186/s13045-021-01223-x. View

4.
Zhao D, Qiao J, He H, Song J, Zhao S, Yu J . TFPI2 suppresses breast cancer progression through inhibiting TWIST-integrin α5 pathway. Mol Med. 2020; 26(1):27. PMC: 7133004. DOI: 10.1186/s10020-020-00158-2. View

5.
Wang X, Penalva L, Yuan H, Linnoila R, Lu J, Okano H . Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol Cancer. 2010; 9:221. PMC: 2939568. DOI: 10.1186/1476-4598-9-221. View